These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7556514)

  • 1. Changes in tissue responsiveness to hormones and neurotransmitters during aging.
    Roth GS
    Exp Gerontol; 1995; 30(3-4):361-8. PubMed ID: 7556514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in hormone and neurotransmitter action with aging].
    Rot Dzh
    Fiziol Zh (1978); 1990; 36(5):82-9. PubMed ID: 1980249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aging on mechanisms of alpha-adrenergic and dopaminergic action.
    Roth GS
    Fed Proc; 1986 Jan; 45(1):60-4. PubMed ID: 3000837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered striatal dopaminergic and cholinergic reciprocal inhibitory control and motor behavioral decrements in senescence.
    Joseph JA; Roth GS
    Ann N Y Acad Sci; 1988; 521():110-22. PubMed ID: 3288037
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha 1-adrenergic and muscarinic-cholinergic stimulated inositol trisphosphate production may proceed through different post-receptor signal transduction pathways in parotid acini.
    Kowatch MA; Roth GS
    Biochem Biophys Res Commun; 1991 May; 176(3):1291-7. PubMed ID: 1645540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of muscarinic M3-like receptors and beta-adrenoceptors, but not M2-like muscarinic receptors or alpha-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro.
    Niittykoski M; Ruotsalainen S; Haapalinna A; Larson J; Sirviö J
    Neuroscience; 1999 Apr; 90(1):95-105. PubMed ID: 10188937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha adrenergic and cholinergic-muscarinic regulation of adenosine cyclic 3',5'-monophosphate levels in the rat parotid.
    Oron Y; Kellogg J; Larner J
    Mol Pharmacol; 1978 Nov; 14(6):1018-30. PubMed ID: 32474
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of food mastication on rat parotid gland adrenergic and cholinergic cell surface receptors.
    Johnson DA; Cardenas HL
    Crit Rev Oral Biol Med; 1993; 4(3-4):591-7. PubMed ID: 8397003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of muscarinic regulation of striatal dopamine function in senescence.
    Joseph JA; Roth GS
    Neurochem Int; 1992 Mar; 20 Suppl():237S-240S. PubMed ID: 1365433
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation of striatal dopamine receptors and improvement of motor performance in senescence.
    Joseph JA; Roth GS
    Ann N Y Acad Sci; 1988; 515():355-62. PubMed ID: 3284425
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of altered hormone and neurotransmitter action during aging: the role of impaired calcium mobilization.
    Roth GS
    Ann N Y Acad Sci; 1988; 521():170-6. PubMed ID: 2897815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic, alpha-adrenergic and peptide receptors regulate the same calcium influx sites in the parotid gland.
    Putney JW
    J Physiol; 1977 Jun; 268(1):139-49. PubMed ID: 195043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural pathways and neurotransmitters affecting melatonin synthesis.
    Ebadi M; Govitrapong P
    J Neural Transm Suppl; 1986; 21():125-55. PubMed ID: 2875124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization.
    Roth GS
    Annu Rev Gerontol Geriatr; 1990; 10():132-46. PubMed ID: 1983283
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of neurotransmitter chemistry of central nervous system neurons in primary tissue culture.
    Thomas WE
    Life Sci; 1986 Jan; 38(4):297-308. PubMed ID: 2418325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface?
    Joseph JA; Dalton TK; Roth GS; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.
    Zhou FM; Wilson C; Dani JA
    Neuroscientist; 2003 Feb; 9(1):23-36. PubMed ID: 12580337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of platelet-activating factor synthesis by neurotransmitters in salivary glands.
    Dohi T; Itadani K; Yamaki H; Akagawa Y; Morita K; Kitayama S
    J Dent Res; 1997 Jan; 76(1):568-74. PubMed ID: 9042079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.